Top compounds associated with response to RNF165


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.094 0.002
mRNA BMS-345541 GDSC1000 pan-cancer AAC 0.098 0.002
mRNA JW-74 CTRPv2 pan-cancer AAC 0.17 0.002
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.002
mRNA manumycin A CTRPv2 pan-cancer AAC 0.11 0.002
mRNA XMD14-99 GDSC1000 pan-cancer AAC 0.1 0.002
mRNA Topotecan CTRPv2 pan-cancer AAC 0.12 0.002
mRNA TPCA-1 GDSC1000 pan-cancer AAC 0.089 0.002
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.13 0.002
Download CSV